Saskatchewan’s bioeconomy is poised for sustainable long term growth. While attracting investment may be a challenge, there exists in Saskatchewan an enviable mix of capacity spread throughout industry, government and universities.s – in a way that is more sustainable and friendly to the environment. Already a Canadian bioscience leader, Saskatchewan is poised to become a bright spot for innovation. When biotech boomed in the early 1990s and early 2000s, a genetics professor with a new discovery could expect millions from investors eager to be part of the next big thing. Those days are pretty much past, says David Gauthier, CEO of the Entrepreneurial Foundation of Saskatchewan. “Getting to cash flow is a huge challenge because private equity has moved to later-stage deals. Investors know it’s harder to make money during early stages. It takes a long time and there’s a high failure rate,” says Gauthier, whose organization advises entrepreneurs seeking financing to grow, transition or reach stability.
Gauthier believes biobusiness has a bright future and Saskatchewan will play a leading role. “The good thing is that because of new research technologies, genomics, screening, marker assisted breeding, we have more capabilities on the research side. We also have more diverse biotech companies in the province using molecular and biotech tools to support different business models,” Gauthier says. Saskatchewan’s traditional strengths as an agricultural centre also play a role, says Jerome Konecsni, Director General of NRC’s Plant Biotechnology Institute. “Saskatchewan has many advantages, including 40 per cent of Canada’s arable land. We have skilled producers and a good distribution system,” Konecsni says. Add to the mix a healthy business atmosphere and one of the lowest tax rates for manufacturers, and the province is more than competitive. But Konecsni notes that skilled personnel are still needed on the processing side of the equation. “I believe we’re on the right track. The province has identified three pillars for innovation strategy, based on natural advantages. Encouraging more industrial investment is an important part of the plan,” he says. Konecsni was recently appointed CEO of Innovation Saskatchewan, assuming his new position at the end of September.
“One of the things that blew me away when I got here, was how incredibly effective and functional the research community is here. There is a lot of collaboration whether you’re
Need for bio With plentiful natural resources increasingly in demand, some might think Saskatchewan could enjoy prosperity just relying on its natural bounty. But that would be a mistake, says Peter Phillips, Professor, Johnson-Shoyama Graduate School of Public Policy at the U of S.
Proof of the concept, he notes, lies in the value now being realized because of strategic investment in Saskatchewan’s agrifood cluster in decades past. “If you look at Canada, every province used to have an agriculture college and federal laboratory. Many now do not. Saskatoon is now extremely competitive because it has these things – if you’re a firm looking to do bExit fullscreenasic research and adapt technologies and products to new production and supply chains, it’s not like there are hundreds of candidate cities,” Phillips says. Ag-West Bio could be considered one of those early investments, and Wilf Keller, the organization’s President and CEO says it is essential that the public and policy makers understand the potential role of bioscience in economic and human health terms.
It’s a new era, with the potential for developing new genetic strains in crops and livestock, ensuring adequate food as the climate changes, and allowing a better understanding of the role of food and food ingredients in human health, says Keller. Bioscience will provide new methods of diagnosing or preventing disease, and healthier ways of creating renewable energy and bioproducts, such as plastics and lubricants. “Our environment, our economy and our health; these are things that matter to all of us.” Written by Dale Worobec for the Ag-West Bio 2010-2011 Annual Report. |
Genetic ModificationVaccinesGenomicsGreen technologyEnvironmentBusinessFoodNatural Health ProductsRegulatoryResearchFarmingHealth.OutreachEducationBulletinBlog
Leave a Reply
Your email address will not be published. Required fields are marked *